NewAmsterdam Pharma Company N.V. (NAMS)
NASDAQ: NAMS · IEX Real-Time Price · USD
20.30
-0.28 (-1.36%)
Jul 2, 2024, 4:00 PM EDT - Market closed

NAMS Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Year
Current2023202220212020
Market Capitalization
1,8271,087847173134
Market Cap Growth
149.34%28.43%389.21%29.00%-
Enterprise Value
1,310709349113132
PE Ratio
--5.53-35.16-3.64-19.14
PS Ratio
-69.467.75--
PB Ratio
4.133.391.853.06-10.44
P/FCF Ratio
--6.9376.21-5.16-18.39
P/OCF Ratio
--6.9374.63-5.16-18.43
EV/Sales Ratio
-45.303.20--
EV/EBITDA Ratio
--3.61-14.70-2.40-20.10
EV/EBIT Ratio
--3.61-14.69-2.40-20.10
EV/FCF Ratio
--4.5231.43-3.36-18.16
Debt / Equity Ratio
0.000.000.000.00-
Debt / EBITDA Ratio
-0.00-0.010.00-
Debt / FCF Ratio
-0.000.01-0.01-
Quick Ratio
8.176.9513.265.965.77
Current Ratio
8.176.9513.265.967.90
Asset Turnover
-0.030.380-
Interest Coverage
---77.86-100.67-15.71
Return on Equity (ROE)
--49.30%-9.40%-318.40%-
Return on Assets (ROA)
--42.90%-8.40%-35.00%-
Return on Capital (ROIC)
--63.43%-0.83%-70.02%51.52%
Earnings Yield
-18.08%-2.84%-27.44%-5.23%
FCF Yield
-14.43%1.31%-19.39%-5.44%
Buyback Yield / Dilution
-14.92%-25.32%-337.60%-155.70%-
Total Shareholder Return
-14.92%-25.32%-337.60%-155.70%-
Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).